Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Toward a drug development path that targets metastatic progression in osteosarcoma.

Toward a drug development path that targets metastatic progression in osteosarcoma. Clin Cancer Res. 2014 Aug 15; 20(16):4200-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.